Literature DB >> 10201521

Animal models of psoriasis - what can we learn from them?

M P Schön1.   

Abstract

Research into the pathogenesis of psoriasis has been hampered by the lack of an animal disease resembling this common human skin disorder. Over the past few years, however, various rodent models that mirror aspects of the psoriatic phenotype and pathogenesis have become available. Here, the most prominent models are compared with human psoriasis and potential uses for psoriasis research are reviewed. Asebia (ab), flaky skin (fsn), and chronic proliferative dermatitis (cpd) are spontaneous mouse mutations with psoriasiform skin alterations of unclear pathogenesis. Transgenic mice with cutaneous overexpression of cytokines, such as interferon-gamma, interleukin-1alpha, keratinocyte growth factor, transforming growth factor-alpha, interferon-6, vascular endothelial growth factor, or bone morphogenic protein-6, are valuable tools for studying in vivo effects of individual cytokines in the pathogenesis of psoriasiform features. Psoriasiform lesions also were seen in beta2-integrin hypomorphic mice backcrossed to the PL/J strain and in beta1-integrin transgenic mice. A T cell-based immunopathogenesis of psoriasiform features was shown in a form of graft-versus-host disease in scid/scid mice reconstituted with CD4+/CD45RB(hi) T lymphocytes as well as in HLA-B27/hbeta2m transgenic rats, demonstrating that dysregulated T cells can induce psoriasiform skin alterations without a primary epithelial abnormality. Finally, xenotransplantation models using human skin grafted on to immunodeficient mice are attractive, as different cell types and some environmental factors leading to psoriasiform features may be studied in human tissue. Overall, although there is no animal model imitating psoriasis completely, many aspects of this common human skin disorder are mirrored in the currently available models and psoriatic plaques can be created in xenotransplantation models.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201521     DOI: 10.1046/j.1523-1747.1999.00538.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

Review 1.  Animal models of psoriasis and psoriatic arthritis: an update.

Authors:  Curdin Conrad; Frank O Nestle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Psoriasis: what we have learned from mouse models.

Authors:  Erwin F Wagner; Helia B Schonthaler; Juan Guinea-Viniegra; Erwin Tschachler
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

3.  SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.

Authors:  Yanhua Liang; John P Sundberg
Journal:  J Dermatol Sci       Date:  2011-05-07       Impact factor: 4.563

4.  Sampling of disease biomarkers from skin for theranostic applications.

Authors:  Makoto Ogura; Sumit Paliwal; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

5.  Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.

Authors:  Yangping Wu; Xiangzheng Chen; Xiaojun Ge; Hongwei Xia; Yuxi Wang; Siyuan Su; Wenting Li; Tinghan Yang; Mingtian Wei; Hang Zhang; Lantu Gou; Jiong Li; Xian Jiang; Jinliang Yang
Journal:  J Mol Med (Berl)       Date:  2015-09-18       Impact factor: 4.599

6.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

Authors:  Daniel Voskas; Nina Jones; Paul Van Slyke; Celina Sturk; Wing Chang; Alex Haninec; Yael Olya Babichev; Jennifer Tran; Zubin Master; Stephen Chen; Nicole Ward; Maribelle Cruz; Jamie Jones; Robert S Kerbel; Serge Jothy; Lina Dagnino; Jack Arbiser; Giannoula Klement; Daniel J Dumont
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.

Authors:  Erin Paul; Rachel Cronan; Paula J Weston; Kim Boekelheide; John M Sedivy; Sang-Yun Lee; David L Wiest; Murray B Resnick; Jan E Klysik
Journal:  Mamm Genome       Date:  2009-01-15       Impact factor: 2.957

8.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

9.  Expression of CC chemokine ligand 20 and CC chemokine receptor 6 mRNA in patients with psoriasis vulgaris.

Authors:  Yan Wu; Jiawen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

10.  Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.

Authors:  Allen G Li; Donna Wang; Xin-Hua Feng; Xiao-Jing Wang
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.